Jeremy Millar
Jeremy Millar
Alfred Health
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ...
The lancet oncology 6 (9), 659-668, 2005
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
DP Dearnaley, MR Sydes, JD Graham, EG Aird, D Bottomley, RA Cowan, ...
The lancet oncology 8 (6), 475-487, 2007
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results …
P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ...
BJU international 109, 22-29, 2012
Activation of thymic regeneration in mice and humans following androgen blockade
JS Sutherland, GL Goldberg, MV Hammett, AP Uldrich, SP Berzins, ...
The Journal of Immunology 175 (4), 2741-2753, 2005
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
DP Dearnaley, G Jovic, I Syndikus, V Khoo, RA Cowan, JD Graham, ...
The lancet oncology 15 (4), 464-473, 2014
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience
JE Sylvester, PD Grimm, JC Blasko, J Millar, PF Orio, S Skoglund, ...
International Journal of Radiation Oncology* Biology* Physics 67 (1), 57-64, 2007
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-urinary group
MA Sidhom, AB Kneebone, M Lehman, KL Wiltshire, JL Millar, ...
Radiotherapy and Oncology 88 (1), 10-19, 2008
Human immunodeficiency virus–related primary central nervous system lymphoma: Factors influencing survival in 111 patients
ME Newell, JF Hoy, SG Cooper, B DeGraaff, AE Grulich, M Bryant, ...
Cancer 100 (12), 2627-2636, 2004
AP hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy–Adjuvant Versus Early …
M Pearse, C Fraser‐Browne, ID Davis, GM Duchesne, R Fisher, ...
BJU international 113, 7-12, 2014
In vivo characterization and numerical simulation of prostate properties for non‐thermal irreversible electroporation ablation
RE Neal, JL Millar, H Kavnoudias, P Royce, F Rosenfeldt, A Pham, ...
The Prostate 74 (5), 458-468, 2014
The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry
M Weerakoon, N Papa, N Lawrentschuk, S Evans, J Millar, M Frydenberg, ...
BJU Int 115 (Suppl 5), 50-6, 2015
A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized respectable cancer of the esophagus
BH Burmeister
Prog Proc Am Soc Clin Oncol 21, 130a, 2002
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011
SM Evans, JL Millar, ID Davis, DG Murphy, DM Bolton, GG Giles, ...
Medical journal of Australia 198 (10), 540-545, 2013
High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer
DR Zwahlen, N Andrianopoulos, B Matheson, GM Duchesne, JL Millar
Brachytherapy 9 (1), 27-35, 2010
Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors
BR Hindson, JL Millar, B Matheson
Brachytherapy 12 (1), 50-55, 2013
Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer
DR Zwahlen, JD Ruben, P Jones, F Gagliardi, JL Millar, U Schneider
International Journal of Radiation Oncology* Biology* Physics 74 (2), 539-545, 2009
Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy
SG Williams, JL Millar, GM Duchesne, MJ Dally, PL Royce, RM Snow
Radiotherapy and oncology 73 (1), 33-38, 2004
Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer
JJ Tjandra, DM Reading, SA McLachlan, IF Gunn, MD Green, ...
Diseases of the colon & rectum 44 (8), 1113-1122, 2001
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
A Kneebone, C Fraser-Browne, GM Duchesne, R Fisher, M Frydenberg, ...
The Lancet Oncology 21 (10), 1331-1340, 2020
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20